tirzepatide indications fda Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Eli Lilly withdraws tirzepatide application

Tirzepatide Oral Dissolving Tablets have not undergone clinical trials

Lean tissue accounted for approximately 39% of total weight lost (Wilding et al., NEJM , 2021)

Can I get these medications just for weight loss, or only for diabetes

Monjauro Mounjaro, FDA-approved in 2022 for the treatment of type 2 diabetes, is one of Eli Lillys most widely discussed drugs due to its reported weight loss benefits

Our model projects Lillys trajectory assuming current growth and gradual multiple compression as the GLP-1 franchise matures

Most Doctors will NOT prescribe phentermine longer than a 3-month time period because it is well known that the benefits of phentermine start to decline after that time period